Related references
Note: Only part of the references are listed.3D printing of layered brain-like structures using peptide modified gellan gum substrates
Rodrigo Lozano et al.
BIOMATERIALS (2015)
An overview on neuroprotective effects of isothiocyanates for the treatment of neurodegenerative diseases
Sabrina Giacoppo et al.
FITOTERAPIA (2015)
Neurodegenerative diseases in the era of targeted therapeutics: how to handle a tangled issue
George K. Tofaris et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2015)
Prospects for polymer therapeutics in Parkinson's disease and other neurodegenerative disorders
Ben Newland et al.
PROGRESS IN POLYMER SCIENCE (2015)
Ferulic Acid: A Hope for Alzheimer's Disease Therapy from Plants
Antonella Sgarbossa et al.
NUTRIENTS (2015)
Co-immunization with DNA and protein mixture: A safe and efficacious immunotherapeutic strategy for Alzheimer's disease in PDAPP mice
Si Liu et al.
SCIENTIFIC REPORTS (2015)
3D-printer visualization of neuron models
Robert A. McDougal et al.
FRONTIERS IN NEUROINFORMATICS (2015)
A Comprehensive Library of Familial Human Amyotrophic Lateral Sclerosis Induced Pluripotent Stem Cells
Ying Li et al.
PLOS ONE (2015)
Encapsulated cell therapy for neurodegenerative diseases: From promise to product
Dwaine F. Emerich et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
Dual-functional nanoparticles targeting amyloid plaques in the brains of Alzheimer's disease mice
Chi Zhang et al.
BIOMATERIALS (2014)
Convection-Enhanced Drug Delivery to the Brain: Therapeutic Potential and Neuropathological Considerations
Neil U. Barua et al.
BRAIN PATHOLOGY (2014)
Is there still any hope for amyloid-based immunotherapy for Alzheimer's disease?
Francesco Panza et al.
CURRENT OPINION IN PSYCHIATRY (2014)
Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting
Hitendra S. Mahajan et al.
DRUG DELIVERY (2014)
Preparation, characterization, in vivo biodistribution and pharmacokinetic studies of donepezil-loaded PLGA nanoparticles for brain targeting
Bhavna et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2014)
Analysis of focused ultrasound-induced blood-brain barrier permeability in a mouse model of Alzheimer's disease using two-photon microscopy
Alison Burgess et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Engineering theranostic nanovehicles capable of targeting cerebrovascular amyloid deposits
Edward K. Agyare et al.
JOURNAL OF CONTROLLED RELEASE (2014)
A short review on the implications of base excision repair pathway for neurons: Relevance to neurodegenerative diseases
Anil K. Mantha et al.
MITOCHONDRION (2014)
Brain Uptake of a Zidovudine Prodrug after Nasal Administration of Solid Lipid Microparticles
Alessandro Dalpiaz et al.
MOLECULAR PHARMACEUTICS (2014)
3D bioprinting of tissues and organs
Sean V. Murphy et al.
NATURE BIOTECHNOLOGY (2014)
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Stephen Salloway et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Intrathecal delivery of protein therapeutics to the brain: A critical reassessment
Pericles Calias et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Protein folding and misfolding in the neurodegenerative disorders: A review
N. B. Boshette et al.
REVUE NEUROLOGIQUE (2014)
Direct cellular delivery of human proteasomes to delay tau aggregation
Dong Hoon Han et al.
NATURE COMMUNICATIONS (2014)
Large-scale generation of human iPSC-derived neural stem cells/early neural progenitor cells and their neuronal differentiation
Leonardo D'Aiuto et al.
ORGANOGENESIS (2014)
Immunotherapy for Alzheimer's disease: past, present and future
Brian Spencer et al.
FRONTIERS IN AGING NEUROSCIENCE (2014)
Smuggling Drugs into the Brain: An Overview of Ligands Targeting Transcytosis for Drug Delivery across the Blood–Brain Barrier
Julia Georgieva et al.
Pharmaceutics (2014)
Highly Stabilized Curcumin Nanoparticles Tested in an In Vitro Blood-Brain Barrier Model and in Alzheimer's Disease Tg2576 Mice
Kwok Kin Cheng et al.
AAPS JOURNAL (2013)
B6 Peptide-Modified PEG-PLA Nanoparticles for Enhanced Brain Delivery of Neuroprotective Peptide
Zhongyang Liu et al.
BIOCONJUGATE CHEMISTRY (2013)
Delivery of siRNA to the brain using a combination of nose-to-brain delivery and cell-penetrating peptide-modified nano-micelles
T. Kanazawa et al.
BIOMATERIALS (2013)
Intranasal Insulin as a Treatment for Alzheimer's Disease: A Review of Basic Research and Clinical Evidence
Jessica Freiherr et al.
CNS DRUGS (2013)
Vitamin D: Preventive and Therapeutic Potential in Parkinson’s disease
Yan Liu et al.
CURRENT DRUG METABOLISM (2013)
Molecular Properties of Lysine Dendrimers and their Interactions with Aβ-Peptides and Neuronal Cells
I.M. Neelov et al.
CURRENT MEDICINAL CHEMISTRY (2013)
Bioprinting Toward Organ Fabrication: Challenges and Future Trends
Ibrahim T. Ozbolat et al.
IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING (2013)
VEGF-releasing biodegradable nanospheres administered by craniotomy: A novel therapeutic approach in the APP/Ps1 mouse model of Alzheimer's disease
Enara Herran et al.
JOURNAL OF CONTROLLED RELEASE (2013)
The Use of Borneol as an Enhancer for Targeting Aprotinin-Conjugated PEG-PLGA Nanoparticles to the Brain
Lin Zhang et al.
PHARMACEUTICAL RESEARCH (2013)
Targeted Delivery of Nano-Therapeutics for Major Disorders of the Central Nervous System
Huile Gao et al.
PHARMACEUTICAL RESEARCH (2013)
Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?
Matthias van Woensel et al.
Cancers (2013)
From Molecular to Nanotechnology Strategies for Delivery of Neurotrophins: Emphasis on Brain-Derived Neurotrophic Factor (BDNF)
Claire Géral et al.
Pharmaceutics (2013)
Drug delivery to the brain in Alzheimer's disease: Consideration of the blood-brain barrier
William A. Banks
ADVANCED DRUG DELIVERY REVIEWS (2012)
Polymeric nanoparticles for drug delivery to the central nervous system
Toral Patel et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
α7 Nicotinic Acetylcholine Receptor Mediated Neuroprotection in Parkinson's Disease
Jun Kawamata et al.
CURRENT DRUG TARGETS (2012)
Exploiting the Properties of Biomolecules for Brain Targeting of Nanoparticulate Systems
S. Cramer et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Pharmacokinetic behavior and efficiency of acetylcholinesterase inhibition in rat brain after intranasal administration of galanthamine hydrobromide loaded flexible liposomes
Weize Li et al.
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2012)
Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting
Mohammad Fazil et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Increased encapsulated cell biodelivery of nerve growth factor in the brain by transposon-mediated gene transfer
L. Fjord-Larsen et al.
GENE THERAPY (2012)
Development and evaluation of thymoquinone-encapsulated chitosan nanoparticles for nose-to-brain targeting: a pharmacoscintigraphic study
Sanjar Alam et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2012)
Challenges in drug delivery to the brain: Nature is against us
Silke Krol
JOURNAL OF CONTROLLED RELEASE (2012)
Lysosomal enzyme can bypass the blood-brain barrier and reach the CNS following intranasal administration
Daniel A. Wolf et al.
MOLECULAR GENETICS AND METABOLISM (2012)
The promise of induced pluripotent stem cells in research and therapy
Daisy A. Robinton et al.
NATURE (2012)
Nanotechnology for neurodegenerative disorders
Francesca Re et al.
MATURITAS (2012)
Intranasal delivery of siRNA to the olfactory bulbs of mice via the olfactory nerve pathway
Dan B. Renner et al.
NEUROSCIENCE LETTERS (2012)
Intranasal deferoxamine improves performance in radial arm water maze, stabilizes HIF-1α, and phosphorylates GSK3β in P301L tau transgenic mice
J. M. Fine et al.
EXPERIMENTAL BRAIN RESEARCH (2012)
Dopamine-loaded chitosan nanoparticles: formulation and analytical characterization
Elvira De Giglio et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2011)
Curcumin-decorated nanoliposomes with very high affinity for amyloid-β1-42 peptide
Spyridon Mourtas et al.
BIOMATERIALS (2011)
The binding affinity of anti-Aβ1-42 MAb-decorated nanoliposomes to Aβ1-42 peptides in vitro and to amyloid deposits in post-mortem tissue
Mara Canovi et al.
BIOMATERIALS (2011)
Targeting the brain with PEG-PLGA nanoparticles modified with phage-displayed peptides
Jingwei Li et al.
BIOMATERIALS (2011)
Characterization and evaluation of chitosan nanoparticles for dopamine brain delivery
Adriana Trapani et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2011)
Neurotherapeutic applications of nanoparticles in Alzheimer's disease
Jasjeet Kaur Sahni et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Development and evaluation of polymer nanoparticles for oral delivery of estradiol to rat brain in a model of Alzheimer's pathology
G. Mittal et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Detection of amyloid plaques targeted by USPIO-Aβ1-42 in Alzheimer's disease transgenic mice using magnetic resonance microimaging
Jing Yang et al.
NEUROIMAGE (2011)
Imaging and drug delivery using theranostic nanoparticles
Siti M. Janib et al.
ADVANCED DRUG DELIVERY REVIEWS (2010)
Nanoparticle-based theranostic agents
Jin Xie et al.
ADVANCED DRUG DELIVERY REVIEWS (2010)
Advances in the treatment of neurodegenerative disorders employing nanotechnology
Girish Modi et al.
YEAR IN NEUROLOGY 2 (2010)
Lipid-based nanoparticles with high binding affinity for amyloid-β1-42 peptide
Marco Gobbi et al.
BIOMATERIALS (2010)
Neuroprotective effects of emodin in rat cortical neurons against β-amyloid-induced neurotoxicity
Tao Liu et al.
BRAIN RESEARCH (2010)
Intranasal drug delivery of didanosine-loaded chitosan nanoparticles for brain targeting; an attractive route against infections caused by aids viruses
Abeer M. Al-Ghananeem et al.
JOURNAL OF DRUG TARGETING (2010)
Efavirenz-loaded polymeric micelles for pediatric anti-HIV pharmacotherapy with significantly higher oral bioavailaibility
Diego A. Chiappetta et al.
NANOMEDICINE (2010)
Functionalized gold nanoparticles: a detailed in vivo multimodal microscopic brain distribution study
Fernanda Sousa et al.
NANOSCALE (2010)
Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases
Reinhard Gabathuler
NEUROBIOLOGY OF DISEASE (2010)
Quinoline-n-butylcyanoacrylate-based nanoparticles for brain targeting for the diagnosis of Alzheimer's disease
Padmakar V. Kulkarni et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2010)
Central Nervous System Penetration for Small Molecule Therapeutic Agents Does Not Increase in Multiple Sclerosis- and Alzheimer's Disease-Related Animal Models Despite Reported Blood-Brain Barrier Disruption
Ziqiang Cheng et al.
DRUG METABOLISM AND DISPOSITION (2010)
Amyloid-Beta Associated with Chitosan Nano-Carrier has Favorable Immunogenicity and Permeates the BBB
Zhang Songjiang et al.
AAPS PHARMSCITECH (2009)
Ultrasensitive and Highly Selective Detection of Alzheimer's Disease Biomarker Using Two-Photon Rayleigh Scattering Properties of Gold Nanoparticle
Adria Neely et al.
ACS NANO (2009)
Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB)
Karsten Ulbrich et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2009)
Trends in the Molecular Pathogenesis and Clinical Therapeutics of Common Neurodegenerative Disorders
Yahya E. Choonara et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2009)
Design, biometric simulation and optimization of a nano-enabled scaffold device for enhanced delivery of dopamine to the brain
Samantha Pillay et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2009)
Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles
Kamila B. Kurakhmaeva et al.
JOURNAL OF DRUG TARGETING (2009)
Delivery of Nerve Growth Factor to Brain Via Intranasal Administration and Enhancement of Brain Uptake
Siva Ram Kiran Vaka et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Nanotechnological applications for the treatment of neurodegenerative disorders
Girish Modi et al.
PROGRESS IN NEUROBIOLOGY (2009)
Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease
Barnabas Wilson et al.
BRAIN RESEARCH (2008)
Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticles
Barnabas Wilson et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2008)
Improved oral bioavailability and brain transport of Saquinavir upon administration in novel nanoemulsion formulations
Tushar K. Vyas et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Pluronic block copolymers: Evolution of drug delivery concept from inert nanocarriers to biological response modifiers
Elena V. Batrakova et al.
JOURNAL OF CONTROLLED RELEASE (2008)
In vitro and in vivo demonstration of risperidone implants in mice
C. Rabin et al.
SCHIZOPHRENIA RESEARCH (2008)
Direct cell writing of 3D microorgan for in vitro pharmacokinetic model
Robert Chang et al.
TISSUE ENGINEERING PART C-METHODS (2008)
Spatio-temporal analysis of molecular delivery through the blood-brain barrier using focused ultrasound
J. J. Choi et al.
PHYSICS IN MEDICINE AND BIOLOGY (2007)
Advances in the treatment of Parkinson's disease
Neha Singh et al.
PROGRESS IN NEUROBIOLOGY (2007)
Multifunctional drugs with different CNS targets for neuropsychiatric disorders
Cornelis J. Van der Schyf et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Blood-brain barrier targeting of BDNF improves motor function in rats with middle cerebral artery occlusion
Yun Zhang et al.
BRAIN RESEARCH (2006)
Minocycline confers early but transient protection in the immature brain following focal cerebral ischemia-reperfusion
C Fox et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2005)
The genetic epidemidogy of neurodegenerative disease
L Bertram et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Dopamine-, L-DOPA-, adrenaline-, and noradrenaline-induced growth of Au nanoparticles: Assays for the detection of neurotransmitters and of tyrosinase activity
R Baron et al.
ANALYTICAL CHEMISTRY (2005)
Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease
DG Georganopoulou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Striatal implantation of GDNF releasing biodegradable microspheres promotes recovery of motor function in a partial model of Parkinson's disease
C Jollivet et al.
BIOMATERIALS (2004)
Pluronic® block copolymers as modulators of drug efflux transporter activity in the blood-brain barrier
AV Kabanov et al.
ADVANCED DRUG DELIVERY REVIEWS (2003)
Surgically implantable long-term antipsychotic delivery systems for the treatment of schizophrenia
SJ Siegel et al.
NEUROPSYCHOPHARMACOLOGY (2002)
Development of microspheres for neurological disorders: From basics to clinical applications
JP Benoit et al.
JOURNAL OF CONTROLLED RELEASE (2000)
Intracerebral implantation of NGF-releasing biodegradable microspheres protects striatum against excitotoxic damage
P Menei et al.
EXPERIMENTAL NEUROLOGY (2000)
Share Paper
